These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 827402)

  • 21. Increase of serum growth hormone concentration following thyrotropin-releasing hormone injection in patients with acromegaly or gigantism.
    Irie M; Tsushima T
    J Clin Endocrinol Metab; 1972 Jul; 35(1):97-100. PubMed ID: 4624350
    [No Abstract]   [Full Text] [Related]  

  • 22. Paradoxical responsiveness of growth hormone to corticotropin-releasing factor in acromegaly.
    Pieters GF; Hermus AR; Smals AG; Kloppenborg PW
    J Clin Endocrinol Metab; 1984 Mar; 58(3):560-2. PubMed ID: 6420444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of Ritalin, CB-154 and various drugs of serum GH in acromegalics (author's transl)].
    Kanatsuka A; Makino H; Matsushima Y; Osegawa M; Yamamoto M; Kumagai A
    Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):636-47. PubMed ID: 99332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal growth hormone responsiveness to stimuli in women with active celiac sprue.
    Peracchi M; Molteni N; Cantalamessa L; Bardella MT; Peracchi G; Orsatti A; Faggioli P; Bianchi PA
    Am J Gastroenterol; 1992 May; 87(5):580-3. PubMed ID: 1595643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do "so-called" normal growth hormone concentrations (2-5 micrograms/l) indicate cure in acromegaly?
    Levitt NS; Ratanjee BD; Abrahamson MJ
    Horm Metab Res; 1995 Apr; 27(4):185-8. PubMed ID: 7750902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
    Felt V; Nedvídková J
    Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
    [No Abstract]   [Full Text] [Related]  

  • 27. [Attempt at suppressing the THR-stimulated plasma growth hormone increase with the use of L-dopa in a cromegaly].
    Kasperlik-Zaluska A; Migdalska B; Wiśniewska-Woźniak T; Kaniewski M
    Endokrynol Pol; 1977; 28(1):31-5. PubMed ID: 401736
    [No Abstract]   [Full Text] [Related]  

  • 28. Thyrotropin-releasing hormone (TRH) does not suppress growth hormone response to L-dopa in insulin-dependent diabetes mellitus.
    Krassowski J; Jeske W; Zgliczyński S
    Endokrynol Pol; 1992; 43(3):344-8. PubMed ID: 1345575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure of somatostatin to suppress thyrotropin releasing factor and luteinizing hormone releasing factor-induced growth hormone release in acromegaly.
    Giustina G; Reschini E; Peracchi M; Cantalamessa L; Cavagnini F; Pinto M; Bulgheroni P
    J Clin Endocrinol Metab; 1974 May; 38(5):906-9. PubMed ID: 4207370
    [No Abstract]   [Full Text] [Related]  

  • 30. [GH and PRL after TRH and hpGRF(1-40) administration in 2 cases of acromegaly with hyperprolactinemia].
    Sampaolo G; Faloia E; Sarzani R; Bartolacci V; Schiavo P; Butini L; Morosini P
    Recenti Prog Med; 1987 Mar; 78(3):115-8. PubMed ID: 3110882
    [No Abstract]   [Full Text] [Related]  

  • 31. Differences in autonomity of growth hormone secretion in patients with acromegaly.
    Hanew K; Aida M; Tano T; Ojima M; Nishizato K
    Tohoku J Exp Med; 1976 Oct; 120(2):159-67. PubMed ID: 824758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pituitary-thyroid axis in acromegaly.
    Eskildsen PC; Kruse A; Kirkegaard C
    Horm Metab Res; 1988 Dec; 20(12):755-7. PubMed ID: 3146541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of thyrotropin-releasing hormone on growth hormone release in normal subjects and in patients with depression, anorexia nervosa and acromegaly.
    Maeda K
    Kobe J Med Sci; 1976 Dec; 22(4):263-72. PubMed ID: 829578
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of thyroliberin (TRH), bromocriptine and cyproheptadine on somatotropin secretion in acromegaly.
    Pawlikowski M; Strejczek H; Owczarczyk I; Komorowski J
    Mater Med Pol; 1980; 12(1-2):70-3. PubMed ID: 6799708
    [No Abstract]   [Full Text] [Related]  

  • 35. TRH-induced growth hormone release in insulin-dependent diabetes mellitus.
    Krassowski J; Jeske W; Zgliczyński S
    Horm Metab Res; 1984 Dec; 16 Suppl 1():119-22. PubMed ID: 6442706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevations in plasma growth hormone concentration after luteinizing hormone-releasing hormone (LRH) in patients with active acromegaly.
    Faglia G; Beck-Peccoz P; Travaglini P; Paracchi A; Spada A; Lewin A
    J Clin Endocrinol Metab; 1973 Aug; 37(2):338-40. PubMed ID: 4198260
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hormonal evaluation of 27 patients with acromegaly].
    Villabona C; Novials A; Soler J; Morató J; Gómez JM; Navarro MA
    Med Clin (Barc); 1985 Feb; 84(6):219-22. PubMed ID: 3920452
    [No Abstract]   [Full Text] [Related]  

  • 38. Paradoxic elevation in serum GH by hypothalamic releasing hormones predicts GH response to acute SMS 201-995 administration.
    Candrina R
    Recenti Prog Med; 1991 Jan; 82(1):13-6. PubMed ID: 1902962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naloxone influence on the growth hormone, prolactin and thyrotropin response to thyrotropin releasing hormone in acromegalic patients.
    De Marinis L; Mancini A; Zuppi P; Fiumara C; Conte G; Sammartano L; Fabrizi ML; Valle D
    Exp Clin Endocrinol Diabetes; 1996; 104(1):67-71. PubMed ID: 8750573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Assessment of biological and hormonal diagnostic criteria in acromegaly (author's transl)].
    Bodson A; Crabbé J
    Ann Endocrinol (Paris); 1980; 41(3):225-6. PubMed ID: 6774658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.